C93.0 Acute monoblastic/monocytic leukaemia - analogs
Description «C93.0 Acute monoblastic/monocytic leukaemia» | ||||||||
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 40% Compare C94 Other leukaemias of specified cell type
- 40% Compare C94.2 Acute megakaryoblastic leukaemia
- 40% Compare C95.0 Acute leukaemia of unspecified cell type
- 40% Compare C95 Leukaemia of unspecified cell type
- 40% Compare C92.4 Acute promyelocytic leukaemia [PML]
- 40% Compare C92.5 Acute myelomonocytic leukaemia
- 32% Compare C91.0 Acute lymphoblastic leukaemia [ALL]
- 24% Compare C91.1 Chronic lymphocytic leukaemia of B-cell type
- 23% Compare C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
- 23% Compare C91.9 Lymphoid leukaemia, unspecified
- 23% Compare C92 Myeloid leukaemia
- 23% Compare C92.7 Other myeloid leukaemia
- 23% Compare C91.5 Adult T-cell lymphoma/leukaemia [HTLV-1-associated]
- 23% Compare C91 Lymphoid leukaemia
- 23% Compare C93 Monocytic leukaemia
- 23% Compare C90.1 Plasma cell leukaemia
- 23% Compare C94.7 Other specified leukaemias
- 23% Compare C92.2 Atypical chronic myeloid leukaemia, BCR/ABL-negative
- 23% Compare C96.9 Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
- 23% Compare C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
- 23% Compare C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissues
- 23% Compare C95.9 Leukaemia, unspecified
- 23% Compare C95.1 Chronic leukaemia of unspecified cell type
- 20% Compare C92.1 Chronic myeloid leukaemia [CML], BCR/ABL-positive
- 15% Compare C92.0 Acute myeloblastic leukaemia [AML]
- 10% Compare C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct
- 10% Compare C18.2 Malignant neoplasm, ascending colon
- 10% Compare C18.4 Malignant neoplasm, transverse colon
- 10% Compare C40.2 Malignant neoplasm, long bones of lower limb
- 10% Compare D37.6 Neoplasm of uncertain or unknown behaviour, liver, gallbladder and bile ducts
- 10% Compare D14.3 Benign neoplasm, bronchus and lung
- 10% Compare C52 Malignant neoplasm of vagina
- 10% Compare C62 Malignant neoplasm of testis
- 10% Compare C62.1 Malignant neoplasm, descended testis
- 10% Compare C50.0 Malignant neoplasm, nipple and areola
- 10% Compare C41.1 Malignant neoplasm, mandible
- 10% Compare C18 Malignant neoplasm of colon
- 10% Compare C22 Malignant neoplasm of liver and intrahepatic bile ducts
- 10% Compare C40.1 Malignant neoplasm, short bones of upper limb
- 10% Compare C41.8 Malignant neoplasm, overlapping lesion of bone and articular cartilage
- 10% Compare C78.0 Secondary malignant neoplasm of lung
- 10% Compare C76.0 Malignant neoplasm, head, face and neck
- 10% Compare C18.6 Malignant neoplasm, descending colon
- 10% Compare C79.7 Secondary malignant neoplasm of adrenal gland
- 10% Compare C62.9 Malignant neoplasm, testis, unspecified
- 10% Compare C15.1 Malignant neoplasm, thoracic part of oesophagus
- 10% Compare C08.0 Malignant neoplasm, submandibular gland
- 10% Compare C77.9 Secondary and unspecified malignant neoplasm, lymph node, unspecified
- 10% Compare C77.8 Secondary and unspecified malignant neoplasm, lymph nodes of multiple regions
- 10% Compare C70.1 Malignant neoplasm, spinal meninges
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnosis.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.